论文信息 - A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours. - 字舞流文

A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours.

J. Schellens | A. Le Cesne | M. D. de Jonge | M. Langenberg | K. Hsu | S. Macé | M. Dickson | G. Tuffal | A. Wagner | K. Thomas | V. D. de Weger | W. Zheng